Breakthrough Psoriasis in Patients Receiving Biologicals
Thomas Damsin, Gilles Absil, Florence Libon, Nazli Tassoudji, Arjen F Nikkels Department of Dermatology and Venerology, CHU of Sart Tilman, University of Liège B-4000, Liège, BelgiumCorrespondence: Arjen F Nikkels, Department of Dermatology and Venereology, CHU of Sart Tilman, University of Liège, B...
Saved in:
| Main Authors: | Damsin T, Absil G, Libon F, Tassoudji N, Nikkels AF |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2025-01-01
|
| Series: | Psoriasis: Targets and Therapy |
| Subjects: | |
| Online Access: | https://www.dovepress.com/breakthrough-psoriasis-in-patients-receiving-biologicals-peer-reviewed-fulltext-article-PTT |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Leptin: a gender and obesity-related marker predictive of metabolic comorbidities and therapeutic response to anti-IL-23 biologic drugs in psoriatic patients
by: Roberta Belli, et al.
Published: (2025-07-01) -
Assessment of The Impact of Apremilast on Levels of IL-17, IL-23, and Lipids in Obese Psoriatic Patient
by: Haitham M. Saad, et al.
Published: (2024-12-01) -
Short-Term Oral Administration of 1.5 μg/kg bw/day of Deoxynivalenol Significantly Exacerbates Inflammatory and Itching Symptoms in a Mouse Model of Imiquimod-Induced Psoriasis
by: Takayoshi Miyamoto, et al.
Published: (2025-01-01) -
Management of Systemic Anti-psoriatic Drugs in Psoriasis Patients with Concurrent Paraplegia or Tetraplegia: Insights From a 6-Year Multicenter, Retrospective Observational Study
by: Giovanni Damiani, et al.
Published: (2025-01-01) -
Intra-class switch among interleukin-17 inhibitors for the treatment of plaque psoriasis: a single-center experience
by: Gioele Ghezzi, et al.
Published: (2024-11-01)